On the other hand, SUMO2 and SUMO3 expression were found to be elevated in human patients with heart failure, and transgenic overexpression of SUMO2 in experimental models resulted in cardiomyopathy-associated heart failure [26]. Here, SUMO2 is linked to heart failure.